Efficacy and safety of palbociclib in heavily pretreated patients with HR+/HER2- metastatic breast cancer. [electronic resource]
Producer: 20180816Description: 537-544 p. digitalISSN:- 1744-8301
- Adult
- Antineoplastic Agents -- administration & dosage
- Breast Neoplasms -- drug therapy
- Female
- Humans
- Kaplan-Meier Estimate
- Middle Aged
- Neoplasm Metastasis
- Neoplasm Staging
- Piperazines -- administration & dosage
- Protein Kinase Inhibitors -- administration & dosage
- Pyridines -- administration & dosage
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Retreatment
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.